Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Connectors Part 8
The type 2 diabetes segment dominated the market with a 55% share in 2025 because GLP-1 therapies have been used for glycemic control for a long time, and diabetes is very common worldwide
In this article, well explore why GLP-1s can cause constipation and other gastrointestinal issues and how you can manage these side effects and get relief
The total annual cost difference is substantial: NHS route : 9.90 monthly (or free if exempt) = approximately 119 annually, or 111.60 with PPC Private route : 150300 monthly = 1,8003,600 annually, plus consultation fees It is important to note that NHS access to GLP-1 medications for weight management remains limited due to NICE eligibility criteria and local commissioning decisions, which may necessitate private treatment for some patients who do not meet strict NHS criteria
The active ingredientsemaglutide itselfis identical in both formulations, meaning the biological effect on GLP-1 receptors is the same
